Pay in installments of $6.38 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
For Your Every Summer RSVP, with Code: SUMMER15
Description
Ozempic maker Novo Nordisk says it will study drug's effects on alcohol consumption but isn't focused on addiction CNN Wegovy, Ozempic and Mounjaro can change the way food tastes, study shows The Mirror Semaglutide Weight Loss Shots in Brandon & Tampa Bay, FL What is Wegovy for Weight Loss? Role in Losing Pounds Dr. Brandon Richland, MD




Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 216 reviews
Sort
Product Reviews
★★★★★ 5
Green spray glitter
Color: Green
Very glittery and sprays good
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 3, 2026
★★★★★ 4
Glitter everywhere
Color: Gold
Heavy coverage but beautiful
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 27, 2026
★★★★★ 2
Can doesn’t spray properly
Color: Silver
Terrible stuck on the first spray entire can wasted . Waste of money
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 26, 2026
★★★★★ 5
Great
Color: Silver
Perfect
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 26, 2026
★★★★★ 5
Loved
Color: Blue
Glitter good but smell nit so much
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 2, 2026
recommand products
GLP-1 Support Premium Patch Pack by PatchAid – Bariatric Eating
24.54
Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished
21.69
GLP-1 trends 2025: real-world data, patient outcomes & future therapies
25.85
Diagram showing the mechanism of action of retatrutide
27.10
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
25.04




